Afimetoran Uses, Dosage, Side Effects and more
Afimetoran is an immunomodulator and an antagonist of toll-like receptors 7 and 8. It is also is under investigation in clinical trial NCT04269356 (Study to Assess the Way the Body Absorbs, Distributes, Breaks Down and Eliminates Radioactive BMS-986256 in Healthy Male Participants).
| Attribute | Details |
|---|---|
| Trade Name | Afimetoran |
| Generic | Afimetoran |
| Afimetoran Other Names | Afimetoran, BMS-986256 |
| Type | |
| Formula | C26H32N6O |
| Weight | Average: 444.583 Monoisotopic: 444.263759674 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
How Afimetoran works
Afimetoran acts as an antagonist of TLR 7/8.
